| REVIEW ARTICLE |
|
| Year : 2022 | Volume
: 6
| Issue : 4 | Page : 201-209 |
|
|
Pulmonary complications and 30-day mortality rate in COVID-19 patients undergoing surgery: A systematic review and meta-analysis
I Made Gede Widnyana, Tjokorda Gde Agung Senapathi, Marilaeta Cindryani, Nova Juwita, Bianca Jeanne
Department of Anesthesiology and Intensive Care, Faculty of Medicine, University of Udayana, Bali, Indonesia
Correspondence Address:
Nova Juwita
Department of Anesthesiology and Intensive Care, Faculty of Medicine, University of Udayana, Jl. PB Sudirman, Denpasar 80232, Bali
Indonesia
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/bjoa.bjoa_182_22
|
|
|
Hundreds of surgeries are postponed every day during the global COVID -19 pandemic. The hospital and clinicians are in dilemma scheduling elective procedures during the pandemic. The current study was designed to evaluate postoperative pulmonary complications and mortality in COVID-19 patients in a systematic review and meta-analysis of globally published peer-reviewed literatures. A systematic literature search was conducted using the selection criteria in five databases. A quality assessment was made with a validated Newcastle-Ottawa Scale. The meta-analysis worked as a generic inverse variance meta-analysis. A total of 308 articles were identified from different databases and 5 articles with a total 1408 participants were selected for evaluation after successive screenings. The meta-analysis revealed a high global rate of postoperative mortality among COVID-19 patients, as high as 23% (95% CI: 15 to 26), and high postoperative pulmonary complications including pneumonia and acute respiratory distress syndrome. The 30-days mortality rate and prevalence of pulmonary complications were high. There was one death for every five COVID-19 patients undergoing surgical procedures, indicating the need for mitigating strategies to decrease perioperative mortality, transmission to healthcare workers, and non-COVID-19 patients. Larger samples and/or multicenter trials are needed to explore the perioperative mortality dan morbidity rate of patients with COVID-19 undergoing surgeries, and in particular, factors with the highest impact on perioperative mortality. There should be a clinical guideline to determine when to operate or not to operate on patients with COVID-19 for elective and emergency surgeries. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
